Innovation unique to Randox, Biochip Array Technology is fast and powerful, delivering multiple results from a single patient sample. A world’s first, Biochip uses algorithms to empower clinicians to accurately identify 175 diseases. To date, £440 million has been invested over 31 years of research, leading to 80 scientific publications and 204 patents filed across immunoassay, toxicology, food diagnostics, and molecular applications. Our vast test menu consists of many novel markers and comprises over 12,000 targets.

Multiplex Testing
Simultaneous detection of up to 100 markers reduces the amount of time spent on individual tests and associated laboratory costs.
Versatile Test Menu
Our diverse test menu comprises toxicology, molecular, clinical immunoassay, and critical care biochips including many novel and advanced disease markers.
Improved Diagnostics
Increases the amount of patient information available allowing for more informed decisions, risk stratification, and triage.
Improved Patient Management
Reduce unnecessary referrals and invasive procedures in low-risk patients and expedite high risk patients.
Reduce Costs
Reduce the burden on healthcare resources, improve preventative care and reduce costs associated with progressed diseases.
Flexible
A range of semi-automated and fully automated analysers are available to meet the demand of all laboratory throughputs.
Choose from the Randox Evidence, Evidence+, Investigator, MultiSTAT or Evolution to begin your Biochip journey today!
Fully Automated

Evidence MultiSTAT
Semi-Automated

Evidence Investigator
Fully-Automated

Evidence RABTA